Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Gattermann

Showing results (11-20 of 158) with videos related to

Pageof 16
Sort By:
Current Pharmaceutical Design|May 11, 2012
Pathophysiological and clinical aspects of iron chelation therapy in MDSNorbert Gattermann
Med (New York, N.Y.)|March 9, 2024
Imetelstat: Finally a disease-modifying treatment for lower-risk myelodysplastic syndromes?Fatemeh Majidi, Norbert Gattermann
Cancer|July 25, 2007
Valproic acid for the treatment of myeloid malignanciesAndrea Kuendgen, Norbert Gattermann
Best Practice & Research. Clinical Haematology|February 11, 2014
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?David P Steensma, Norbert Gattermann
Critical Reviews in Oncology/Hematology|June 23, 2019
Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questionsHeather A Leitch, Norbert Gattermann
Annals of Hematology|October 13, 2010
Iron overload in MDS-pathophysiology, diagnosis, and complicationsNorbert Gattermann, Eliezer A Rachmilewitz
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 13, 2006
Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLCMichael Wulfert, Christoph Tapprich, Norbert Gattermann
Experimental Hematology|March 31, 2011
Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changesVerena Schildgen, Michael Wulfert, Norbert Gattermann
Blood|July 19, 2002
New prognostic parameters for chronic myelomonocytic leukemiaUlrich Germing, Corinna Strupp, Manuel Aivado, et al.
Deutsches Arzteblatt International|December 5, 2013
Myelodysplastic syndromes: diagnosis, prognosis, and treatmentUlrich Germing, Guido Kobbe, Rainer Haas, et al.
Pageof 16

Showing results (11-20 of 158) with videos related to

Sort By:
Pageof 16
Current Pharmaceutical Design|May 11, 2012
Pathophysiological and clinical aspects of iron chelation therapy in MDSNorbert Gattermann
Med (New York, N.Y.)|March 9, 2024
Imetelstat: Finally a disease-modifying treatment for lower-risk myelodysplastic syndromes?Fatemeh Majidi, Norbert Gattermann
Cancer|July 25, 2007
Valproic acid for the treatment of myeloid malignanciesAndrea Kuendgen, Norbert Gattermann
Best Practice & Research. Clinical Haematology|February 11, 2014
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?David P Steensma, Norbert Gattermann
Critical Reviews in Oncology/Hematology|June 23, 2019
Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questionsHeather A Leitch, Norbert Gattermann
Annals of Hematology|October 13, 2010
Iron overload in MDS-pathophysiology, diagnosis, and complicationsNorbert Gattermann, Eliezer A Rachmilewitz
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 13, 2006
Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLCMichael Wulfert, Christoph Tapprich, Norbert Gattermann
Experimental Hematology|March 31, 2011
Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changesVerena Schildgen, Michael Wulfert, Norbert Gattermann
Blood|July 19, 2002
New prognostic parameters for chronic myelomonocytic leukemiaUlrich Germing, Corinna Strupp, Manuel Aivado, et al.
Deutsches Arzteblatt International|December 5, 2013
Myelodysplastic syndromes: diagnosis, prognosis, and treatmentUlrich Germing, Guido Kobbe, Rainer Haas, et al.
Pageof 16